Your browser doesn't support javascript.
loading
Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db/db mice.
Hsieh, Pei-Shan; Ho, Hsieh-Hsun; Hsieh, Shih-Hung; Kuo, Yi-Wei; Tseng, Hsiu-Ying; Kao, Hui-Fang; Wang, Jiu-Yao.
Afiliação
  • Hsieh PS; Research and Development Department, Glac Biotech Co., Ltd, Tainan, Taiwan.
  • Ho HH; Research and Development Department, Glac Biotech Co., Ltd, Tainan, Taiwan.
  • Hsieh SH; Research and Development Department, Glac Biotech Co., Ltd, Tainan, Taiwan.
  • Kuo YW; Research and Development Department, Glac Biotech Co., Ltd, Tainan, Taiwan.
  • Tseng HY; Department of Pediatrics, National Cheng Kung University Hospital, Tainan, Taiwan.
  • Kao HF; Department of Pediatrics, National Cheng Kung University Hospital, Tainan, Taiwan.
  • Wang JY; Department of Pediatrics, National Cheng Kung University Hospital, Tainan, Taiwan a122@mail.ncku.edu.tw.
BMJ Open Diabetes Res Care ; 8(1)2020 04.
Article em En | MEDLINE | ID: mdl-32332068
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Limosilactobacillus reuteri / Ligilactobacillus salivarius Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Experimental / Diabetes Mellitus Tipo 2 / Limosilactobacillus reuteri / Ligilactobacillus salivarius Idioma: En Ano de publicação: 2020 Tipo de documento: Article